Vaxart, Inc. Stock-Based Compensation
Vaxart, Inc. (VXRT) reported Stock-Based Compensation of $2.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- Vaxart, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.29M, a 39.18% decline year-over-year.
- Vaxart, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.48M, a 39.73% decline year-over-year.
- Vaxart, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.72M, a 27.13% decline year-over-year.
- Vaxart, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.02M, a 18.46% decline year-over-year.
- Vaxart, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $14.13M, a 4.01% increase from fiscal 2022.
- Vaxart, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $13.59M, a 53.23% increase from fiscal 2021.
- Vaxart, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $8.87M, a 103.46% increase from fiscal 2020.
- Vaxart, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $4.36M, a 595.06% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.29M derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | $2.77M 10-Q · filed 2026-08-06 | $4.49M derived: sum of 3 quarters · filed 2026-08-06 | $6.51M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $1.48M S-1 · filed 2026-05-08 | $3.20M derived: sum of 2 quarters · filed 2026-05-08 | $5.22M derived: sum of 3 quarters · filed 2026-05-08 | $7.34M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $1.72M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $3.73M derived: sum of 2 quarters · filed 2026-05-08 | $5.86M derived: sum of 3 quarters · filed 2026-08-06 | $8.31M S-1 · filed 2026-05-08 | ||
| 2025-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $4.14M derived: sum of 2 quarters · filed 2026-08-06 | $6.60M 10-Q · filed 2025-11-13 | $8.95M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $2.12M derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | $4.58M 10-Q · filed 2026-08-06 | $6.93M derived: sum of 3 quarters · filed 2026-08-06 | $9.41M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $2.46M S-1 · filed 2026-05-08 | $4.81M derived: sum of 2 quarters · filed 2026-05-08 | $7.29M derived: sum of 3 quarters · filed 2026-05-08 | $9.84M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $2.35M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $4.83M derived: sum of 2 quarters · filed 2026-05-08 | $7.38M derived: sum of 3 quarters · filed 2026-05-08 | $11.50M S-1 · filed 2026-05-08 | ||
| 2024-09-30 | $2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $5.03M derived: sum of 2 quarters · filed 2025-11-13 | $9.15M 10-Q · filed 2025-11-13 | $12.86M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $6.67M 10-Q · filed 2025-08-13 | $10.39M derived: sum of 3 quarters · filed 2025-08-13 | $14.23M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $4.12M 10-Q · filed 2025-05-13 | $7.83M derived: sum of 2 quarters · filed 2025-05-13 | $11.67M derived: sum of 3 quarters · filed 2025-05-13 | $15.60M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $7.56M derived: sum of 2 quarters · filed 2025-03-20 | $11.48M derived: sum of 3 quarters · filed 2025-03-20 | $14.13M 10-K · filed 2025-03-20 | ||
| 2023-09-30 | $3.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $7.77M derived: sum of 2 quarters · filed 2024-11-13 | $10.42M 10-Q · filed 2024-11-13 | $13.81M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $3.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $6.57M 10-Q · filed 2024-08-08 | $9.97M derived: sum of 3 quarters · filed 2024-08-08 | $13.61M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $2.65M 10-Q · filed 2024-05-13 | $6.04M derived: sum of 2 quarters · filed 2024-05-13 | $9.68M derived: sum of 3 quarters · filed 2024-05-13 | $13.10M derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $7.04M derived: sum of 2 quarters · filed 2024-03-14 | $10.46M derived: sum of 3 quarters · filed 2024-03-14 | $13.59M 10-K · filed 2024-03-14 | ||
| 2022-09-30 | $3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $7.06M derived: sum of 2 quarters · filed 2023-11-02 | $10.19M 10-Q · filed 2023-11-02 | $13.11M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | $3.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $6.55M 10-Q · filed 2023-08-03 | $9.46M derived: sum of 3 quarters · filed 2023-08-03 | $11.56M derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | $3.13M 10-Q · filed 2023-05-04 | $6.04M derived: sum of 2 quarters · filed 2023-05-04 | $8.14M derived: sum of 3 quarters · filed 2023-05-04 | $10.75M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $5.01M derived: sum of 2 quarters · filed 2023-03-15 | $7.62M derived: sum of 3 quarters · filed 2023-03-15 | $8.87M 10-K · filed 2023-03-15 | ||
| 2021-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.70M derived: sum of 2 quarters · filed 2022-11-09 | $5.95M 10-Q · filed 2022-11-09 | $6.44M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.85M 10-Q · filed 2022-08-08 | $4.34M derived: sum of 3 quarters · filed 2022-08-08 | $5.26M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | $1.25M 10-Q · filed 2022-05-09 | $1.74M derived: sum of 2 quarters · filed 2022-05-09 | $2.65M derived: sum of 3 quarters · filed 2022-05-09 | $5.51M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.40M derived: sum of 2 quarters · filed 2022-02-24 | $4.26M derived: sum of 3 quarters · filed 2022-02-24 | $4.36M 10-K · filed 2022-02-24 | ||
| 2020-09-30 | $915.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.77M derived: sum of 2 quarters · filed 2021-11-04 | $3.87M 10-Q · filed 2021-11-04 | $4.01M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $2.96M 10-Q · filed 2021-08-05 | $3.09M derived: sum of 3 quarters · filed 2022-02-24 | $3.24M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-31 | $96.00K 10-Q · filed 2021-05-06 | $233.00K derived: sum of 2 quarters · filed 2022-02-24 | $379.00K derived: sum of 3 quarters · filed 2022-02-24 | $559.00K derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $283.00K derived: sum of 2 quarters · filed 2022-02-24 | $463.00K derived: sum of 3 quarters · filed 2022-02-24 | $627.00K 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $146.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $326.00K derived: sum of 2 quarters · filed 2020-11-12 | $490.00K 10-Q · filed 2020-11-12 | $642.00K derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | $180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $344.00K 10-Q · filed 2020-08-06 | $496.00K derived: sum of 3 quarters · filed 2021-02-25 | $679.00K derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | $164.00K 10-Q · filed 2020-05-12 | $316.00K derived: sum of 2 quarters · filed 2021-02-25 | $499.00K derived: sum of 3 quarters · filed 2021-02-25 | $617.00K derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $335.00K derived: sum of 2 quarters · filed 2021-02-25 | $453.00K derived: sum of 3 quarters · filed 2021-02-25 | $539.00K 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $301.00K derived: sum of 2 quarters · filed 2019-11-12 | $387.00K 10-Q · filed 2019-11-12 | $687.00K derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $204.00K 10-Q · filed 2019-08-08 | $504.00K derived: sum of 3 quarters · filed 2019-08-08 | $1.00M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | $86.00K 10-Q · filed 2019-05-09 | $386.00K derived: sum of 2 quarters · filed 2019-05-09 | $886.00K derived: sum of 3 quarters · filed 2019-05-09 | $1.01M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | $800.00K 10-Q · filed 2018-02-06 | $929.00K derived: sum of 3 quarters · filed 2018-08-10 | $477.00K 10-K · filed 2019-02-06 | ||
| 2017-09-30 | $500.00K 10-Q · filed 2017-11-07 | $629.00K derived: sum of 2 quarters · filed 2018-08-10 | $374.00K 10-Q · filed 2018-11-13 | $1.25M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2017-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $253.00K 10-Q · filed 2018-08-10 | $753.00K derived: sum of 3 quarters · filed 2018-08-10 | $1.90M 10-K · filed 2017-09-01 | ||
| 2017-03-31 | $124.00K 10-Q · filed 2018-05-15 | $624.00K derived: sum of 2 quarters · filed 2018-05-15 | $1.40M 10-Q · filed 2017-05-08 | $1.42M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | $900.00K 10-Q · filed 2018-02-06 | $1.30M derived: sum of 3 quarters · filed 2018-02-06 | $1.70M derived: sum of 4 quarters · filed 2018-02-06 | ||
| 2016-09-30 | $400.00K 10-Q · filed 2017-11-07 | $800.00K derived: sum of 2 quarters · filed 2017-11-07 | $1.20M derived: sum of 3 quarters · filed 2017-11-07 | $1.80M derived: sum of 4 quarters · filed 2017-11-07 | ||
| 2016-06-30 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | $800.00K derived: sum of 2 quarters · filed 2017-09-01 | $1.40M derived: sum of 3 quarters · filed 2017-09-01 | $2.00M 10-K · filed 2017-09-01 | ||
| 2016-03-31 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | $1.00M derived: sum of 2 quarters · filed 2017-05-08 | $1.60M 10-Q · filed 2017-05-08 | $2.10M derived: sum of 4 quarters · filed 2017-05-08 | ||
| 2015-12-31 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-06 | $1.20M 10-Q · filed 2017-02-06 | $1.70M derived: sum of 3 quarters · filed 2017-02-06 | $2.30M derived: sum of 4 quarters · filed 2017-02-06 | ||
| 2015-09-30 | $600.00K 10-Q · filed 2016-11-08 | $1.10M derived: sum of 2 quarters · filed 2016-11-08 | $1.70M derived: sum of 3 quarters · filed 2016-11-08 | $2.30M derived: sum of 4 quarters · filed 2016-11-08 | ||
| 2015-06-30 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $1.10M derived: sum of 2 quarters · filed 2016-09-13 | $1.70M derived: sum of 3 quarters · filed 2016-09-13 | $2.10M 10-K · filed 2016-09-13 | ||
| 2015-03-31 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $1.20M derived: sum of 2 quarters · filed 2016-05-10 | $1.60M 10-Q · filed 2016-05-10 | $1.90M derived: sum of 4 quarters · filed 2016-09-13 | ||
| 2014-12-31 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | $1.00M 10-Q · filed 2016-02-08 | $1.30M derived: sum of 3 quarters · filed 2016-09-13 | $1.80M derived: sum of 4 quarters · filed 2016-09-13 | ||
| 2014-09-30 | $400.00K 10-Q · filed 2015-11-06 | $700.00K derived: sum of 2 quarters · filed 2016-09-13 | $1.20M derived: sum of 3 quarters · filed 2016-09-13 | $1.80M derived: sum of 4 quarters · filed 2016-09-13 | ||
| 2014-06-30 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $800.00K derived: sum of 2 quarters · filed 2016-09-13 | $1.40M derived: sum of 3 quarters · filed 2016-09-13 | $1.70M 10-K · filed 2016-09-13 | ||
| 2014-03-31 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-08 | $1.10M derived: sum of 2 quarters · filed 2015-05-08 | $1.40M 10-Q · filed 2015-05-08 | $1.20M 10-Q · filed 2014-05-12 | $1.70M derived: sum of 4 quarters · filed 2015-09-11 | |
| 2013-12-31 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | $900.00K 10-Q · filed 2015-02-06 | $1.20M derived: sum of 3 quarters · filed 2015-09-11 | $1.60M derived: sum of 4 quarters · filed 2015-09-11 | ||
| 2013-09-30 | $300.00K 10-Q · filed 2014-11-07 | $600.00K derived: sum of 2 quarters · filed 2015-09-11 | $1.00M derived: sum of 3 quarters · filed 2015-09-11 | $2.70M derived: sum of 4 quarters · filed 2015-09-11 | ||
| 2013-06-30 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11 | $700.00K derived: sum of 2 quarters · filed 2015-09-11 | $2.40M derived: sum of 3 quarters · filed 2015-09-11 | $2.60M 10-K · filed 2015-09-11 | ||
| 2013-03-31 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | $2.10M derived: sum of 2 quarters · filed 2014-05-12 | $2.30M 10-Q · filed 2014-05-12 | $2.29M 10-Q · filed 2013-05-10 | $2.96M derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-10 | $1.90M 10-Q · filed 2014-02-10 | $1.90M 10-Q · filed 2013-02-11 | $2.56M derived: sum of 3 quarters · filed 2014-02-10 | $3.53M derived: sum of 4 quarters · filed 2014-02-10 | |
| 2012-09-30 | $200.00K 10-Q · filed 2013-11-12 | $858.00K derived: sum of 2 quarters · filed 2013-11-12 | $2.84M 10-Q · filed 2012-11-08 | $1.99M derived: sum of 4 quarters · filed 2013-11-12 | ||
| 2012-06-30 | $658.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $1.63M 10-Q · filed 2012-08-09 | $1.79M derived: sum of 3 quarters · filed 2012-08-09 | $500.00K 10-K · filed 2014-09-30 | ||
| 2012-03-31 | $976.00K 10-Q · filed 2012-05-10 | $1.13M derived: sum of 2 quarters · filed 2012-05-10 | $424.00K 10-Q · filed 2013-05-10 | $2.57M derived: sum of 4 quarters · filed 2012-08-09 | ||
| 2011-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $279.00K 10-Q · filed 2013-02-11 | $1.60M derived: sum of 3 quarters · filed 2012-08-09 | $2.17M 10-K · filed 2012-03-14 | ||
| 2011-09-24 | $796.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $1.44M derived: sum of 2 quarters · filed 2012-08-09 | $2.01M 10-Q · filed 2012-11-08 | $4.04M derived: sum of 4 quarters · filed 2012-08-09 | ||
| 2011-06-30 | $600.00K 10-K · filed 2013-09-27 | |||||
| 2011-06-25 | $645.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $1.22M 10-Q · filed 2012-08-09 | $3.24M derived: sum of 3 quarters · filed 2012-08-09 | $4.04M derived: sum of 4 quarters · filed 2012-08-09 | ||
| 2011-03-26 | $570.00K 10-Q · filed 2012-05-10 | $2.60M derived: sum of 2 quarters · filed 2012-05-10 | $3.39M derived: sum of 3 quarters · filed 2012-05-10 | |||
| 2010-12-25 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $2.82M derived: sum of 2 quarters · filed 2012-03-14 | $3.92M 10-K · filed 2012-03-14 | |||
| 2010-09-25 | $793.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $1.90M 10-Q · filed 2011-11-02 | ||||
| 2010-06-26 | $1.10M 10-Q · filed 2011-08-03 | |||||
| 2009-12-26 | $2.46M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |